Ann C. Gallo, Senior Vice President, Partner, and Global Industry Analyst.
As a global industry analyst in Global Industry Research, Ann specializes in the health care services industry. She conducts fundamental analysis on the companies within her industry and makes buy/sell recommendations to portfolio managers based on her findings and market conditions. Ann is a member of Wellington Management’s health care team, which manages health and biotechnology sector mutual funds and hedge funds, and she currently serves as coordinator for several of the team-managed portfolios.
Prior to joining Wellington Management in 1998, Ann was a health care analyst with BT Alex. Brown (1995 – 1998). She worked as an investment banker and, subsequently, a health care analyst at Piper Jaffray in Minneapolis (1992 – 1995). Previously, she was a financial analyst with Citibank N.A. (1991 – 1992) and an accountant with Coopers & Lybrand (1987 – 1989).
Ann received her MS in finance and applied economics from the Massachusetts Institute of Technology (Sloan, 1991) and her BS in accounting from Boston College (1987).
Managed care companies exhibit innovation, solid fundamentals and low regulatory risk.
Look for leading-edge, cost-effective innovation in products and services.
Healthcare stocks will benefit from policy and regulatory clarity.
Why you should pay attention to the research and treatment of diseases such as cancer and Alzheimer’s.
Demand is high for healthcare services worldwide, and that will remain the case. Find out why innovation is important in that space.
Over the past year, the healthcare sector has suffered due to issues such as controversial drug pricing.